Stock Based Compensation	6 Months Ended
Jul. 02, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Stock Based Compensation	8. Stock Based Compensation During the quarter and six months ended July 2, 2021, the Company issued 5,696 and 467,674 restricted stock units at a weighted average grant-date fair value of $17.55 and $14.59 per share, respectively. As of July 2, 2021, the Company had 1,233,803 restricted stock units outstanding at a weighted average grant-date fair value of $15.74 per share. As of July 2, 2021, $13.2 million of total restricted stock unit compensation expense related to unvested awards had not been recognized and is expected to be recognized over a weighted average period of approximately 2.3 years. As of July 2, 2021, the Company had 21,154 shares of common stock subject to vesting requirements outstanding at a weighted average grant-date fair value of $16.17 per share. As of July 2, 2021, $114 thousand of compensation expense related to common stock subject to vesting requirements had not been recognized and is expected to be recognized over a weighted average period of approximately 1.4 years. Forfeitures for all of the Company’s outstanding equity awards are recognized as incurred.

Stock Based Compensation

6 Months Ended

Jul. 02, 2021

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

8. Stock Based Compensation

During the quarter and six months ended July 2, 2021, the Company issued 5,696 and 467,674 restricted stock units at a weighted average grant-date fair value of $17.55 and $14.59 per share, respectively. As of July 2, 2021, the Company had 1,233,803 restricted stock units outstanding at a weighted average grant-date fair value of $15.74 per share. As of July 2, 2021, $13.2 million of total restricted stock unit compensation expense related to unvested awards had not been recognized and is expected to be recognized over a weighted average period of approximately 2.3 years.

As of July 2, 2021, the Company had 21,154 shares of common stock subject to vesting requirements outstanding at a weighted average grant-date fair value of $16.17 per share. As of July 2, 2021, $114 thousand of compensation expense related to common stock subject to vesting requirements had not been recognized and is expected to be recognized over a weighted average period of approximately 1.4 years.

Forfeitures for all of the Company’s outstanding equity awards are recognized as incurred.